We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05165433
Brief Title: Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (FORTIFY)

First Submitted : December 7, 2021
First Submitted that Met QC Criteria : December 7, 2021
First Posted : December 21, 2021

Last Update Submitted that Met QC Criteria : January 16, 2023
Last Update Posted : January 18, 2023